
Heart in Diabetes (HiD)
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to Heart in Diabetes (HiD) — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
About this event
Heart In Diabetes (HID)
Since you have not shared your client website yet, I am giving you a strong event-level buyer analysis based on the event type, audience profile, and the most likely commercial buyers who would value this attendee data. If you share your client website, I can refine this further and narrow the buyer list to the exact companies, job titles, and industries that match your client product.
Event type: Medical / Clinical Conference, Diabetes, Cardiology, Endocrinology, Prevention, Research, Patient Care, Healthcare Innovation
Likely audience: Physicians, researchers, clinicians, hospital leaders, diabetes educators, pharma teams, medtech teams, device buyers, digital health stakeholders, and healthcare decision-makers
Estimated attendance: Medium to large specialized healthcare audience, usually concentrated among professionals in cardiology, diabetes care, endocrine medicine, clinical research, hospital systems, and industry sponsors. Exact footfall depends on the edition, city, and hosting organization, but the event should be treated as a high-value niche B2B healthcare conference rather than a mass public show.
1️⃣ Who attends: Buyers / Attendees
Heart In Diabetes is likely attended by a highly specialized mix of clinical, scientific, and commercial healthcare professionals. This is not a general audience event. The strongest buyer value comes from people involved in treatment decisions, procurement discussions, clinical trials, education, digital health implementation, and healthcare product adoption.
Main attendee groups:
- Cardiologists, endocrinologists, diabetologists, internists, and metabolic specialists
- Hospital and health system executives involved in diabetes and cardiovascular care programs
- Diabetes educators, nurse practitioners, physician assistants, and care coordinators
- Clinical researchers, principal investigators, and trial site managers
- Pharmaceutical companies working in diabetes, obesity, cardiometabolic disease, and cardiovascular therapeutics
- Medical device companies selling glucose monitoring, insulin delivery, remote monitoring, and diagnostic tools
- Digital health, remote patient monitoring, and care management software providers
- Lab, diagnostics, and medical technology companies
- Academic researchers and teaching hospital faculty
- Patient advocacy organizations and medical associations
The most valuable attendees for attendee-list monetization are not patients, but clinicians, hospital decision-makers, pharma and medtech professionals, research leaders, and healthcare administrators.
2️⃣ Where the show is happening + attendee geographic origin
If this event is being held in the United States, the audience will most likely be a mix of local/regional attendees plus national healthcare professionals traveling for education and networking. If held outside the U.S., the same logic applies: the local host city will generate a strong base, but the subject matter typically attracts a broader national and sometimes international healthcare audience.
Typical geographic origin pattern:
- Local: Physicians, hospital staff, and educators from the host city and nearby metro areas
- National: Clinicians, researchers, pharma teams, and device companies traveling from across the country
- Global: Possible participation from international researchers, medical associations, and global healthcare vendors if the event has a strong scientific reputation
For outreach, the event should be treated as a national-level healthcare buyer source with local concentration around the venue city.
3️⃣ Audience reach: Local / National / Global
Reach type: National with potential global scientific reach
This kind of event usually has strong domestic relevance because diabetes and cardiovascular disease are major public-health priorities in every market. If the conference is associated with a respected medical society, it may also draw global researchers, multinational healthcare brands, and international opinion leaders.
In practical list-selling terms, the event should be positioned as a high-quality healthcare decision-maker event with influence across clinical practice, research, medical education, pharma marketing, and device adoption.
4️⃣ Sample buyer company names + websites
Below is a sample buyer table with the kind of companies that are most likely to be strong fits for this event. These are buyer-style accounts you can use for list building and targeting. The focus is on organizations that would care about cardiometabolic care, diabetes technology, cardiovascular treatment, patient engagement, diagnostics, clinical research, and healthcare purchasing.
| Priority | Company | Website | Best Title to Target | Why This is a Good Buyer Fit |
|---|---|---|---|---|
| 1 | Abbott | abbott.com | Director, Diabetes Marketing / Clinical Affairs Manager / Regional Sales Director | Strong fit for glucose monitoring, diagnostics, and cardiometabolic care engagement. |
| 2 | Dexcom | dexcom.com | Senior Product Manager / Medical Affairs Manager / Market Development Director | Directly aligned with continuous glucose monitoring and clinician education. |
| 3 | Medtronic | medtronic.com | Director, Diabetes Business Unit / Clinical Solutions Manager / Territory Manager | Relevant for insulin delivery, remote monitoring, and diabetes technology. |
| 4 | Roche Diagnostics | roche.com | Product Marketing Manager / Medical Science Liaison / Regional Account Manager | Good fit for diagnostics, lab solutions, and clinician outreach. |
| 5 | Novo Nordisk | novonordisk.com | Market Access Manager / Brand Manager / Medical Affairs Director | Very strong fit for diabetes and obesity-focused commercial and medical teams. |
| 6 | Eli Lilly and Company | lilly.com | Director, Cardiometabolic Strategy / Sales Training Manager / Medical Liaison | Major buyer for diabetes and cardiometabolic treatment ecosystem events. |
| 7 | Sanofi | sanofi.com | Brand Director / Market Access Lead / Medical Affairs Specialist | Relevant for chronic disease, diabetes, and healthcare professional engagement. |
| 8 | Becton, Dickinson and Company | bd.com | Director, Medication Management / Sales Director / Clinical Specialist Manager | Strong fit for injection systems, hospital care, and diabetes-related devices. |
| 9 | Johnson & Johnson MedTech | jnj.com | Clinical Marketing Manager / Strategic Accounts Director / Medical Education Lead | Useful for hospital-based cardiovascular and chronic care connections. |
| 10 | Boston Scientific | bostonscientific.com | Product Manager / Clinical Education Manager / Sales Director | Relevant for cardiovascular and intervention-focused healthcare audiences. |
| 11 | CVS Health | cvshealth.com | Director, Clinical Strategy / Pharmacy Programs Manager / Population Health Lead | Good fit for chronic disease management, pharmacy services, and care pathways. |
| 12 | UnitedHealth Group | unitedhealthgroup.com | Population Health Director / Clinical Programs Manager / Provider Relations Lead | Strong buyer for value-based care, prevention, and disease management programs. |
| 13 | Teladoc Health | teladoc.com | VP, Clinical Partnerships / Product Marketing Director / Digital Health Strategy Lead | Excellent fit for telehealth, remote care, and chronic disease programs. |
| 14 | Omada Health | omadahealth.com | Partnerships Director / Growth Marketing Manager / Clinical Programs Lead | Very relevant for diabetes prevention, behavior change, and digital care delivery. |
| 15 | Verily | verily.com | Program Manager / Partnerships Lead / Clinical Research Operations Director | Strong fit for digital health, research, analytics, and innovation-driven healthcare. |
| 16 | GE HealthCare | gehealthcare.com | Clinical Affairs Manager / Product Marketing Director / Account Executive | Relevant for diagnostics, monitoring, imaging, and hospital technology buyers. |
| 17 | ResMed | resmed.com | Director, Chronic Care Solutions / Clinical Sales Specialist / Partnerships Manager | Good fit for connected health, sleep-apnea overlap, and chronic disease ecosystems. |
| 18 | Pfizer | pfizer.com | Medical Affairs Director / Brand Lead / Market Access Manager | Relevant for cardiometabolic, cardiovascular, and medical education audiences. |
| 19 | Bayer | bayer.com | Medical Affairs Manager / Product Marketing Lead / Strategic Accounts Manager | Useful for cardiovascular, diagnostics, and healthcare partnership programs. |
| 20 | Amgen | amgen.com | Director, Medical Affairs / Sales Training Lead / Market Development Manager | Strong fit for cardiovascular and chronic disease decision-maker engagement. |
Top 5 buyer samples to send first: Abbott, Dexcom, Medtronic, Novo Nordisk, Eli Lilly and Company.
5️⃣ Job profiles, industries & event type
This event is best approached as a healthcare and life-sciences buyer environment. The most useful contacts are not only clinical speakers, but also commercial teams, medical affairs teams, research staff, and healthcare system leaders.
Best job profiles to target:
- Medical Director
- Director, Medical Affairs
- Clinical Affairs Manager
- Clinical Education Manager
- Diabetes Program Director
- Endocrinology Practice Manager
- Cardiology Service Line Director
- Population Health Director
- Health System Strategy Lead
- Product Marketing Manager
- Market Access Manager
- Regional Sales Director
- Territory Manager
- Partnerships Director
- Digital Health Strategy Lead
- Clinical Research Manager
- Principal Investigator
- Research Operations Manager
- Medical Science Liaison
- Healthcare Innovation Lead
Best industry filters to use:
- Hospital & Health Care
- Medical Devices
- Pharmaceuticals
- Biotechnology
- Health, Wellness & Fitness
- Research
- Information Technology & Services
- Computer Software
- Medical Practice
- Mental Health Care
- Insurance
- Government Administration
- Higher Education
- Professional Training & Coaching
- Management Consulting
- Market Research
This event type is especially valuable when the client sells: medical devices, diagnostics, pharma services, digital health, patient engagement, clinical software, healthcare staffing, research tools, or health-system solutions.
6️⃣ Estimated attendance / expected footfall
Since this is a niche healthcare conference, expected footfall is usually measured in quality rather than sheer volume. The attendance may range from a few hundred to a few thousand depending on whether it is a symposium, summit, or larger annual meeting.
Estimated attendance range:
- Small specialized edition: 300–800 attendees
- Mid-size clinical conference: 800–2,000 attendees
- Large annual medical meeting: 2,000–5,000+ attendees
For attendee-list sales, even a smaller version of this event can be highly valuable because the audience is concentrated in premium healthcare roles with commercial and clinical influence.
7️⃣ Key focus areas & buyer engagement
Heart In Diabetes is likely centered around the intersection of diabetes and cardiovascular health. This makes it attractive to organizations that work on chronic disease prevention, treatment adherence, digital care, diagnostics, and clinical decision support.
Likely focus areas:
- Cardiometabolic disease management
- Diabetes prevention and treatment
- Glucose monitoring and insulin delivery
- Cardiovascular risk reduction
- Obesity and metabolic health
- Digital health and remote patient monitoring
- Clinical research and evidence generation
- Patient adherence and outcomes
- Health equity and access to care
- Practice transformation and care pathways
Best buyer engagement angles:
- Clinical education and product awareness
- HCP engagement and medical affairs outreach
- Partnerships with hospitals and academic centers
- Lead generation for chronic disease solutions
- Scientific visibility for pharma and device brands
- Market development for digital health and monitoring products
- Recruitment of healthcare professionals and research collaborators
For your client, the list should not be sold as a generic “attendee list.” It should be framed as a healthcare decision-maker and clinical influencer audience with strong relevance to diabetes, cardiovascular care, medtech, pharma, research, and hospital buying teams.
8️⃣ Client product fit note
You asked me to always base the answer on your client product review and website, and I agree that this is the best way to make the list more accurate. Right now, because the client website has not been shared, I can only give you a strong general buyer map.
If you send your client website, I can immediately refine the answer in these ways:
- Identify the exact buyer companies most likely to purchase attendee data
- Match the best job titles to the product category
- Prioritize the most relevant industries from the list you provided
- Filter out irrelevant attendees and weak-fit companies
- Create a ready-to-use buyer list with priority ranking
Examples of client-product matching:
- If the client sells medical devices, focus on product, clinical, and hospital procurement teams.
- If the client sells digital health software, focus on partnerships, strategy, innovation, and care management leaders.
- If the client sells pharmaceutical services, focus on medical affairs, market access, and brand leadership.
- If the client sells recruitment or staffing, focus on healthcare workforce and clinical operations buyers.
- If the client sells research or data solutions, focus on trial managers, research directors, and academic medical centers.
9️⃣ Final recommendation
Heart In Diabetes is a strong niche healthcare event for attendee-list monetization if your client sells into cardiology, diabetes care, medtech, diagnostics, digital health, pharma, or hospital-based chronic care programs.
The best buyers are not broad consumer health brands. The strongest fit is with organizations that need access to clinical influencers, healthcare buyers, medical educators, and healthcare innovation teams.
Best buyer segments to collect:
- Diabetes and cardiovascular pharmaceutical companies
- Medical device and diagnostic brands
- Hospital and health system leaders
- Digital health and remote monitoring providers
- Clinical research organizations
- Academic medical centers and teaching hospitals
- Healthcare consulting and population health companies
Quality rating for B2B attendee-list sales: 8.5/10
This is a very good event if your client is in healthcare, especially where the buyer is looking for clinical influence, decision-makers, or specialized disease-management audiences. Share the client website, and I can turn this into a far more targeted buyer intelligence report.
Data sheet
| Event Name | Heart in Diabetes (HiD) |
| Event Date | June 19–21, 2026 |
| Event Status | Upcoming |
| Venue | Philadelphia, USA listed by user; exact venue not publicly confirmed in the provided details |
| City | Philadelphia |
| State / Region | Colorado listed in supplied details; this conflicts with Philadelphia and should be treated as unverified |
| Country | United States |
| Organizer | Not publicly confirmed from the supplied event details |
| Official Event Website | Not verified from the supplied details |
| Event Type | Medical / clinical conference focused on cardiovascular and diabetes care |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; Wellness, Health & Fitness |
| Audience Reach | Likely national with specialist international participation, subject to organizer confirmation |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Low at present; user-supplied event data and topical profile available, but current-year public metrics were not verified in the supplied materials |
| Main Purpose of Event | Professional education, clinical knowledge exchange, disease-management strategy, research dissemination, partnership building, and healthcare industry engagement in the overlap between cardiology and diabetes |
Heart in Diabetes (HiD) appears to be a specialist healthcare conference centered on the clinical and scientific relationship between cardiovascular disease and diabetes. Based on the event title and supplied description, the event is likely designed for physicians, endocrinology and cardiology experts, researchers, hospital leadership, diabetes educators, industry teams, and digital health stakeholders involved in prevention, treatment, and long-term patient management.
From a commercial perspective, this is a high-value niche B2B medical event rather than a mass-attendance expo. The strongest lead-generation relevance lies in identifying buyer-side healthcare organizations, provider systems, life sciences firms, device manufacturers, clinical research stakeholders, and decision-makers responsible for therapy adoption, procurement, partnerships, education, and innovation programs. Current-year participation details should be validated against the official organizer site before any attendee-list claims are made.
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Cardiologists and endocrinologists | Academic medical centers, hospitals, specialty practices | Clinical adoption influence, therapy evaluation, referral pathways | High relevance for pharma, diagnostics, devices, digital therapeutics, education platforms |
| Hospital and health system leadership | Integrated delivery networks, teaching hospitals, outpatient networks | Budget ownership, service-line planning, care pathway decisions | Important for enterprise clinical solutions, remote monitoring, population health, procurement discussions |
| Procurement and supply chain teams | Hospitals, group purchasing participants, clinic networks | Vendor selection, contracting, equipment and consumables sourcing | Direct buyer group for devices, diagnostics, software, and support services |
| Clinical research leaders | Universities, CRO-linked centers, research hospitals | Trial design, investigator partnerships, evidence generation | Relevant for sponsors, research vendors, data platforms, lab services |
| Pharma and biotech medical / commercial teams | Drug manufacturers, specialty therapeutics companies | Partnerships, KOL engagement, therapeutic promotion within compliant frameworks | High-value sponsor and buyer-side segment for market intelligence and professional engagement services |
| Medical device and diagnostics teams | CGM, cardiac monitoring, diagnostics, imaging, wearables, intervention support firms | Product placement, channel partnerships, clinician education | Strong relevance for solution selling into diabetes-cardiometabolic care |
| Digital health and health IT leaders | RPM providers, EHR-linked solution vendors, analytics companies, telehealth providers | Technology adoption, integration planning, patient engagement programs | Useful for enterprise partnerships, pilots, interoperability, and outcomes programs |
| Diabetes educators and care program managers | Hospitals, specialty clinics, care management programs | Influence patient engagement tools, adherence programs, education materials | Relevant for education solutions, patient support services, and digital care pathways |
| Association and guideline stakeholders | Professional societies, foundations, medical education bodies | Program influence, professional network access, policy visibility | Useful for partnerships, content sponsorships, and credibility-building |
| Investors and strategic partners | Healthcare investors, strategic business development groups | Evaluate innovation, pipeline strength, commercialization opportunities | Relevant where the event includes innovation showcases or sponsored research visibility |
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Host city | Philadelphia metropolitan healthcare ecosystem | High | Likely draw from hospitals, universities, medical schools, and regional provider systems if Philadelphia is the confirmed host city |
| Host state / region | Verification required due to supplied Philadelphia / Colorado mismatch | Medium | State-level targeting should not be finalized until the official venue listing is confirmed |
| Nearby business hubs | Likely Northeast corridor participants such as Pennsylvania, New Jersey, New York, Maryland, Delaware, Massachusetts | High | Strong concentration of academic medicine, payer networks, pharma, and medtech organizations |
| National reach | U.S. cardiology, endocrinology, diabetes care, and health-system stakeholders | High | Specialist medical conferences often attract national attendance when the agenda and faculty are strong |
| International reach | Possible but not confirmed | Medium | Clinical and research-focused events may attract international faculty, sponsors, or research collaborators; current-year evidence not verified |
| Key trade / referral corridors | Academic medicine, hospital procurement, payer-provider innovation, pharma-medtech collaboration | High | Most relevant for B2B outreach into provider systems, life sciences, research partnerships, and chronic-care technology adoption |
| Reach Level | Assessment | Explanation |
|---|---|---|
| National | Primary classification | The topic focus is specialized but broad enough to attract U.S.-wide clinical, provider, research, life sciences, and digital health participation, subject to official confirmation of the 2026 program |
| Regional | Secondary influence | If held in Philadelphia, the Northeast healthcare corridor would likely be overrepresented in attendee mix |
| Global | Possible but unverified | International scientific participation may occur in this specialty area, but no current-year evidence was verified from supplied materials |
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| Penn Medicine | Academic medical center / provider system | Major Philadelphia-area clinical and research institution relevant to cardiometabolic care | pennmedicine.org | Chief Medical Officer, Cardiology Director, Endocrinology Director, Procurement Manager, Population Health Director | Strong Market Fit, Attendance Not Confirmed |
| Jefferson Health | Health system | Large regional provider with cardiovascular and diabetes management relevance | jeffersonhealth.org | VP Supply Chain, Service Line Director, Clinical Innovation Director, Endocrinology Chair | Strong Market Fit, Attendance Not Confirmed |
| Children’s Hospital of Philadelphia | Pediatric healthcare provider / research institution | Relevant for diabetes, cardiovascular risk, clinical research, and care innovation | chop.edu | Research Director, Clinical Program Manager, Supply Chain Director, Digital Health Director | Strong Market Fit, Attendance Not Confirmed |
| Temple Health | Academic health system | Relevant regional buyer for disease-management solutions and specialist clinical technologies | templehealth.org | Procurement Director, Cardiology Director, Endocrinology Director, Operations Director | Strong Market Fit, Attendance Not Confirmed |
| Main Line Health | Regional health system | Potential buyer of patient-monitoring, care-coordination, and chronic disease tools | mainlinehealth.org | VP Clinical Operations, Supply Chain Director, Population Health Executive | Strong Market Fit, Attendance Not Confirmed |
| University of Pennsylvania Perelman School of Medicine | Academic / research organization | Relevant for faculty participation, investigator collaboration, and CME-linked engagement | med.upenn.edu | Professor of Cardiology, Research Program Director, Clinical Trial Director | Strong Market Fit, Attendance Not Confirmed |
| American Diabetes Association | Association / professional stakeholder | Highly relevant to diabetes education, advocacy, and professional engagement | diabetes.org | Education Director, Partnership Director, Scientific Affairs Lead | Strong Market Fit, Attendance Not Confirmed |
| American Heart Association | Association / professional stakeholder | Relevant due to direct overlap between diabetes and cardiovascular prevention | heart.org | Scientific Program Director, Partnerships Director, Guideline Program Lead | Strong Market Fit, Attendance Not Confirmed |
| Medtronic Diabetes | Medical device manufacturer | Relevant buyer-side and partner-side organization for diabetes technology engagement | medtronicdiabetes.com | Medical Affairs Director, Market Development Director, Strategic Partnerships Director | Strong Market Fit, Attendance Not Confirmed |
| Dexcom | Medical device / CGM company | Relevant to diabetes monitoring, outcomes improvement, and provider adoption discussions | dexcom.com | Regional Business Director, Clinical Affairs Director, Health System Partnerships Lead | Strong Market Fit, Attendance Not Confirmed |
| Abbott Diabetes Care | Medical device / diagnostics company | Important participant type for glucose monitoring, provider partnerships, and cardiometabolic care integration | diabetescare.abbott | National Accounts Director, Medical Affairs Director, Provider Partnerships Manager | Strong Market Fit, Attendance Not Confirmed |
| Novo Nordisk | Pharmaceutical company | Direct relevance to diabetes and cardiometabolic therapeutic strategy | novonordisk.com | Medical Science Liaison Leader, Market Access Director, Partnerships Director | Strong Market Fit, Attendance Not Confirmed |
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Chief Medical Officer | Executive / Clinical Leadership | C-Level | Influences clinical strategy, care pathways, and adoption decisions |
| 2 | Cardiology Director | Clinical | Director | Key stakeholder for heart-disease management solutions |
| 3 | Endocrinology Director | Clinical | Director | Influences diabetes therapy, technology, and care program adoption |
| 4 | Director of Procurement | Procurement / Supply Chain | Director | Controls supplier evaluation and contract pathways |
| 5 | Procurement Manager | Procurement / Supply Chain | Manager | Practical buying role for medical products, software, and services |
| 6 | Population Health Director | Population Health / Operations | Director | Important for chronic disease and outcomes-based initiatives |
| 7 | Digital Health Director | IT / Innovation | Director | Relevant for RPM, software integration, analytics, and patient engagement tools |
| 8 | Clinical Research Director | Research | Director | High-value role for studies, collaborations, and evidence programs |
| 9 | Medical Affairs Director | Medical Affairs | Director | Key role on the life sciences side for scientific engagement and event activation |
| 10 | Strategic Partnerships Director | Business Development | Director | Useful for sponsors, research alliances, channel and program partnerships |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Core provider and health-system audience | Clinical solution sales, procurement, care programs |
| 2 | Medical Devices | Strong fit for monitoring, diagnostics, and intervention tools | Partnerships, sponsorship, channel expansion |
| 3 | Pharmaceuticals | Diabetes and cardiometabolic therapeutics are central to the theme | Medical affairs, market access, KOL engagement |
| 4 | Biotechnology | Relevant for advanced therapies, biomarkers, and R&D collaboration | Research partnerships and scientific outreach |
| 5 | Research | Academic and investigator-led participation is likely | Trial recruitment, collaboration, evidence generation |
| 6 | Higher Education | Medical schools and universities often contribute faculty and research | Faculty outreach, institutional partnerships |
| 7 | Information Technology & Services | Applicable to healthcare analytics, patient engagement, and interoperability | Digital health partnerships and enterprise pilots |
| 8 | Computer Software | Software tools for chronic disease management, analytics, and clinician workflow | SaaS targeting into providers and life sciences firms |
| 9 | Health, Wellness & Fitness | Relevant for prevention, adherence, and lifestyle support programs | Patient support and coaching partnerships |
| 10 | Nonprofit Organization Management | Applicable to disease foundations and professional organizations | Education sponsorship and alliance-building |
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Attendance figure not publicly confirmed by the organizer. | Unconfirmed | No current-year organizer metric verified in supplied details | Should be treated as a specialist medical conference rather than a broad consumer expo |
| Exhibitor count | Not publicly confirmed | Unconfirmed | No exhibitor directory verified from supplied details | Could include sponsors, pharma, devices, diagnostics, and digital health firms if a commercial exhibition exists |
| Buyer count | Not publicly confirmed | Unconfirmed | No buyer or attendee segment total verified | Buyer value is concentrated in provider systems, research institutions, and life sciences stakeholder mix |
| Speaker count | Not publicly confirmed | Unconfirmed | No agenda or faculty list verified | Speaker organizations would materially improve attendee profiling once released |
| Sponsor count | Not publicly confirmed | Unconfirmed | No sponsor page verified | Sponsor roster would be useful for outreach into life sciences and medtech budgets |
| Historical attendance | Not available from supplied details | Historical / prior-year evidence unavailable | No prior-year official metrics provided or verified | Historical organizer data should be added once available |
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Cardiometabolic care integration | Coordinated management of diabetes and cardiovascular risk | Clinical education, pathway design, specialist alignment | Care coordination tools, clinical content, analytics platforms |
| Diabetes technology | Monitoring, adherence, patient data visibility | Provider demos, procurement review, pilot discussions | CGM, RPM, connected devices, patient apps |
| Clinical research | Evidence generation, trial collaboration, data collection | Investigator outreach, site partnerships, publication support | Research services, data platforms, CRO support |
| Hospital procurement | Cost, outcomes, interoperability, compliance | Product evaluations and contracting conversations | Medical supplies, software, diagnostics, support services |
| Digital transformation | Workflow improvement, patient engagement, data integration | IT and innovation stakeholder meetings | Software, analytics, interoperability, telehealth |
| Professional education | Guideline updates and clinician learning | CME-linked sponsorship, faculty visibility, program partnerships | Education technology, publishing, compliant sponsorship programs |
| Population health and prevention | Reducing admissions, improving outcomes, patient adherence | Health-system and payer-provider collaboration | Risk stratification, coaching, care management services |
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | High | The event theme aligns well with high-value healthcare and life sciences decision-makers |
| Decision-maker availability | High | Specialist conferences often attract directors, clinical leaders, researchers, and sponsor-side executives |
| Data collection potential | Medium | Good potential if agenda, faculty, sponsors, and attendee segmentation become public; currently limited by lack of verified 2026 directories |
| Apollo targeting potential | Very High | Strong industry, title, and geography filters exist for providers, medical devices, pharma, and digital health |
| Geographic targeting potential | High | Targeting can focus on Philadelphia / Northeast and broaden to U.S. national specialist audiences |
| Best outreach approach | High | Use topic-led outreach around diabetes-cardiovascular outcomes, care pathways, procurement value, and research collaboration |
| Overall lead quality | High | High-value niche event for healthcare B2B sales, though current-year attendee proof remains limited |
| Best use case | High | ABM targeting, sponsor prospecting, healthcare buyer profiling, and strategic partner mapping |
| Limitations / risks | Medium | Venue/location inconsistency and lack of verified current-year public participant lists reduce certainty for attendee-list claims |
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Medical Devices; Pharmaceuticals; Biotechnology; Research; Higher Education; Information Technology & Services; Computer Software; Health, Wellness & Fitness; Nonprofit Organization Management | Maps the most relevant provider, life sciences, academic, and digital health buyers |
| Departments | Medical; Clinical; Procurement; Supply Chain; Operations; Research; Information Technology; Innovation; Business Development; Partnerships; Medical Affairs | Captures both care delivery and commercial influence functions |
| Seniority | C-Level; VP; Director; Head; Manager | Prioritizes decision-makers and implementation owners |
| Job titles | Chief Medical Officer; Cardiology Director; Endocrinology Director; Director of Procurement; Procurement Manager; Supply Chain Director; Population Health Director; Digital Health Director; Clinical Research Director; Medical Affairs Director; Strategic Partnerships Director; Service Line Director | Highly relevant roles for healthcare buying and influence |
| Geography | United States; Northeast U.S.; Pennsylvania; New Jersey; New York; Maryland; Delaware; Massachusetts; Philadelphia metro | Supports host-market and national specialist targeting |
| Employee size | 201–500; 501–1,000; 1,001–5,000; 5,001–10,000; 10,001+ | Best for health systems, university medicine, and scaled life sciences firms |
| Keywords | diabetes; cardiology; cardiometabolic; endocrine; endocrinology; cardiovascular; population health; remote patient monitoring; CGM; chronic disease management; outcomes; clinical research | Improves event-theme relevance |
| Technologies, if relevant | EHR integration; remote patient monitoring; care management platforms; analytics; telehealth | Useful for digital health and enterprise IT account selection |
| Revenue range, if relevant | $10M+ for specialty firms; $100M+ for scaled health systems and life sciences targets | Helps prioritize budget-bearing accounts |
| Company type | Hospital systems; academic medical centers; universities; medical device companies; pharmaceutical companies; biotech firms; health IT vendors; nonprofits / associations | Aligns search with the most likely buyer clusters |
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| User-supplied event brief | Provided input | Event title, dates, city, country, and topical description | Medium |
| Location data consistency check | Internal validation note | Philadelphia conflicts with state/region listed as Colorado; official venue confirmation required | High |
| Penn Medicine – pennmedicine.org | Organization website | Relevant regional provider target | High for organization existence; not evidence of event attendance |
| Jefferson Health – jeffersonhealth.org | Organization website | Relevant regional provider target | High for organization existence; not evidence of event attendance |
| Children’s Hospital of Philadelphia – chop.edu | Organization website | Relevant pediatric and research target | High for organization existence; not evidence of event attendance |
| American Diabetes Association – diabetes.org | Association website | Relevant diabetes-sector stakeholder target | High for organization existence; not evidence of event attendance |
| American Heart Association – heart.org | Association website | Relevant cardiovascular-sector stakeholder target | High for organization existence; not evidence of event attendance |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to Heart in Diabetes (HiD) — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.